US Stock MarketDetailed Quotes

Insight Molecular Diagnostics (IMDX)

Watchlist
  • 4.020
  • 0.0000.00%
Close Sep 15 16:00 ET
131.55MMarket Cap-2.64P/E (TTM)

Insight Molecular Diagnostics (IMDX) Earnings Dates, Reports & Conference Call

IMDX 2026 Q2 Earnings Dates & Summary

Currency:USDAug 10, 2026

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
437.50K
239.00K
-198.50K
Miss Est.
-15.54%
-53.86%
-45.37%
Net Income
-8.77M
-11.26M
-2.49M
Miss Est.
+9.97%
-15.58%
-28.38%
Strong Buy

Aug 31, 2026

IMDX Revenue, EPS and EBIT Estimates

Revenue

Net Profit

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2026/Q4-- / 473.720K--
--2026/Q3-- / 244.280K--
Aug 10, 20262026/Q2239.000K / 437.500K--
May 13, 20262026/Q132.000K / 227.500K--
Mar 26, 20262025/Q41.139M / 285.000K--
DatePeriodRevenue/EstimateEarnings Call
--2026/Q4-- / 473.720K--
--2026/Q3-- / 244.280K--
Aug 10, 20262026/Q2239.000K / 437.500K--
May 13, 20262026/Q132.000K / 227.500K--
Mar 26, 20262025/Q41.139M / 285.000K--

Unlock Free Earnings Estimates

Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On September 1, U.S. Eastern Time, the U.S. military launched a new round of strikes against Iran in response to recent attempts by the Isla Show More